South African nevirapine policy faces growing pressure.
Baleta
Adele
A
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006078:Government Programs; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D019829:Nevirapine / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011640:Public Policy; D013019:South Africa
D019380:Anti-HIV Agents; D019829:Nevirapine